PharmaCyte Biotech (PMCB) Net Equity Issued and Repurchased (2011 - 2026)
PharmaCyte Biotech (PMCB) posted quarterly Net Equity Issued and Repurchased of -$86419.0 for Q2 2026, down 9720.34% quarter-over-quarter from -$880.0 in Q4 2022.
PharmaCyte Biotech (PMCB) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Net Equity Issued and Repurchased for 13 consecutive years, with -$86419.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Net Equity Issued and Repurchased changed N/A year-over-year to -$86419.0; the TTM figure through Apr 2026 stood at -$86419.0 (changed N/A YoY), while the FY2026 annual figure was $6.2 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased eased to -$86419.0 in Q2 2026 per PMCB's latest filing, from -$880.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $31.7 million in Q2 2022 and bottomed at -$86419.0 in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - | -86,419.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -86,419.00 |
| Apr 30, 2026 | -86,419.00 |
| Oct 31, 2022 | -880.00 |
| Oct 31, 2022 | -880.00 |
| Jul 31, 2022 | 880.00 |
| Jul 31, 2022 | 880.00 |
| Apr 30, 2022 | 31.67 Mn |
| Apr 30, 2022 | 31.67 Mn |
| Oct 31, 2021 | 55.69 Mn |
| Oct 31, 2021 | 55.69 Mn |
| Oct 31, 2020 | 2.84 Mn |
| Oct 31, 2020 | 2.84 Mn |
| Jul 31, 2020 | 1.86 Mn |
| Jul 31, 2020 | 1.86 Mn |
| Apr 30, 2020 | 1.33 Mn |
| Apr 30, 2020 | 1.33 Mn |
| Jan 31, 2020 | 450,000.00 |
| Jan 31, 2020 | 450,000.00 |
| Oct 31, 2019 | 301,000.00 |
| Oct 31, 2019 | 301,000.00 |